| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |